FIELD: organic chemistry, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to inhibitor of integrin expression. Inhibitor comprises as an active component compound of formulas (Ia)
and (Ib)
an agent comprising inhibitor of integrin expression of formulas (Ia) and (Ib) that is used in treatment of artheriosclerosis, psoriasis, osteoporosis, angiogenesis, retinal angiogenesis, diabetic retinopathy, inflammatory diseases and a method for prophylaxis, treatment or relief in disease course associated with the enhanced expression of integrin. Inhibitor of integrin expression elicits the reduced toxicity, high effectiveness and enhanced bioavailability.
EFFECT: valuable medicinal properties of inhibitor.
19 cl, 4 dwg, 326 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NITROGEN-CONTAINING AROMATIC DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR TREATMENT AND USING | 2003 |
|
RU2310651C2 |
| NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
| 3-SUBSTITUTED OXINDOLE DERIVATIVES AS MODULATORS OF POTASSIUM CHANNELS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1996 |
|
RU2165925C2 |
| SULFONAMIDE-CONTAINING INDOLE COMPOUNDS | 2000 |
|
RU2208607C2 |
| GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE INGREDIENT | 2008 |
|
RU2450001C2 |
| BICYCLIC IMIDAZOL DERIVATIVES AS MEDIUM AGAINST VIRUSES OF FLAVIVIRIDAE FAMILY | 2004 |
|
RU2355687C2 |
| NEW BIPHENYL COMPOUND OR ITS SALT | 2016 |
|
RU2726622C2 |
| PYRROLOPYRIDINES EFFECTIVE AS PROTEINKINASE INHIBITORS | 2006 |
|
RU2435769C2 |
| DERIVATIVES OF CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUNDS AND METHOD OF THEIR SYNTHESIS | 1996 |
|
RU2167877C2 |
| METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION | 2018 |
|
RU2789449C2 |
